(AS OF MARCH 31)
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 06/29/2023 | Q2 2023 | -$0.28 | $1.11 M | 07/31/2023 | Q1 2023 | -$0.12 | $1.70 M | 06/28/2023 | Q4 2022 | -$0.50 | $2.43 M | 09/30/2022 | Q3 2022 | -$0.07 | $2.31 M | 07/29/2022 | Q2 2022 | -$0.09 | $0 | 04/28/2022 | Q1 2022 | -$0.04 | $0 | 12/31/2021 | Q4 2021 | -$0.00 | $2.69 M | 09/30/2021 | Q3 2021 | -$0.31 | $2.69 M | 06/30/2021 | Q2 2021 | -$0.44 | $2.52 M | 03/31/2021 | Q1 2021 | $1.75 | $2.64 M |
---|
A. The conference call for EUDA Health Holdings Limited's latest earnings report can be listened to online.
A. The conference call transcript for EUDA Health Holdings Limited's latest earnings report can be read online.
A. EUDA Health Holdings Limited (NASDAQ:EUDAW) has a recorded annual revenue of $3.71 M.
A. EUDA Health Holdings Limited (NASDAQ:EUDAW) has a recorded net income of $3.71 M. EUDA Health Holdings Limited has generated $-0.44 earnings per share over the last four quarters.
A. EUDA Health Holdings Limited (NASDAQ:EUDAW) has a price-to-earnings ratio of -9.38 and price/earnings-to-growth ratio is -0.12.